North Rock Partners, LLC Edwards Lifesciences Corp Transaction History

North Rock Partners, LLC

$1.14 Billion
Q3 2024

A detailed history of North Rock Partners, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, North Rock Partners, LLC holds 9,914 shares of EW stock, worth $747,317. This represents 0.06% of its overall portfolio holdings.

Number of Shares

9,914

Previous 11,658 14.96%

Holding current value

$747,317

Previous $1.08 Million 39.22%

% of portfolio

0.06%

Previous 0.09%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$59.7 - $93.78 $104,116 - $163,552	-1,744 Reduced 14.96%	9,914 $654,000
Q2 2024 Aug 06, 2024	SELL	$84.3 - $94.31 $184,532 - $206,444	-2,189 Reduced 15.81%	11,658 $1.08 Million
Q1 2024 May 07, 2024	BUY	$72.54 - $95.56 $51,068 - $67,274	704 Added 5.36%	13,847 $1.32 Million
Q4 2023 Feb 08, 2024	SELL	$61.71 - $77.76 $22,153 - $27,915	-359 Reduced 2.66%	13,143 $1 Million
Q3 2023 Oct 24, 2023	SELL	$69.28 - $93.38 $79,949 - $107,760	-1,154 Reduced 7.87%	13,502 $935,000
Q2 2023 Aug 02, 2023	SELL	$81.41 - $94.33 $42,903 - $49,711	-527 Reduced 3.47%	14,656 $1.38 Million
Q1 2023 May 03, 2023	BUY	$74.26 - $84.51 $71,141 - $80,960	958 Added 6.73%	15,183 $1.26 Million
Q4 2022 Feb 01, 2023	SELL	$68.3 - $87.44 $83,326 - $106,676	-1,220 Reduced 7.9%	14,225 $1.06 Million
Q3 2022 Nov 02, 2022	SELL	$82.37 - $107.29 $49,010 - $63,837	-595 Reduced 3.71%	15,445 $1.28 Million
Q2 2022 Aug 04, 2022	BUY	$86.5 - $128.27 $151,634 - $224,857	1,753 Added 12.27%	16,040 $1.53 Million
Q1 2022 May 05, 2022	SELL	$101.96 - $128.34 $281,103 - $353,833	-2,757 Reduced 16.18%	14,287 $1.68 Million
Q4 2021 Feb 07, 2022	BUY	$106.37 - $130.68 $40,739 - $50,050	383 Added 2.3%	17,044 $2.21 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $84,797 - $101,146	824 Added 5.2%	16,661 $1.89 Million
Q2 2021 Aug 12, 2021	SELL	$83.84 - $104.76 $112,848 - $141,006	-1,346 Reduced 7.83%	15,837 $1.64 Million
Q1 2021 May 11, 2021	SELL	$78.68 - $90.67 $13,218 - $15,232	-168 Reduced 0.97%	17,183 $1.44 Million
Q4 2020 Feb 08, 2021	SELL	$71.69 - $91.23 $103,376 - $131,553	-1,442 Reduced 7.67%	17,351 $1.58 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $16,327 - $21,247	243 Added 1.31%	18,793 $1.5 Million
Q2 2020 Aug 13, 2020	SELL	$57.54 - $76.95 $115 - $153	-2 Reduced 0.01%	18,550 $1.28 Million
Q2 2020 Aug 11, 2020	BUY	$57.54 - $76.95 $709,122 - $948,331	12,324 Added 197.88%	18,552 $1.28 Million
Q1 2020 May 13, 2020	SELL	$52.41 - $81.0 $5,607 - $8,667	-107 Reduced 1.69%	6,228 $1.18 Million
Q4 2019 Feb 12, 2020	SELL	$71.7 - $82.09 $71 - $82	-1 Reduced 0.02%	6,335 $1.48 Million
Q4 2019 Feb 12, 2020	BUY	$71.7 - $82.09 $55,710 - $63,783	777 Added 13.98%	6,336 $1.48 Million
Q3 2019 Nov 12, 2019	BUY	$61.55 - $75.43 $342,156 - $419,315	5,559 New	5,559 $1.22 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Rock Partners, LLC with notifications on news.

Account

North Rock Partners, LLC Edwards Lifesciences Corp Transaction History